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Abstract
Ammonia is implicated as a neurotoxin in brain metabolic disorders associated with hyperammonemia. Acute ammonia
toxicity can be mediated by an excitotoxic mechanism, oxidative stress and nitric oxide (NO) production. Astrocytes interact
with neurons, providing metabolic support and protecting against oxidative stress and excitotoxicity. Astrocytes also
convert excess ammonia and glutamate into glutamine via glutamine synthetase (GS). Resveratrol, a polyphenol found in
grapes and red wines, exhibits antioxidant and anti-inflammatory properties and modulates glial functions, such as
glutamate metabolism. We investigated the effect of resveratrol on the production of reactive oxygen species (ROS), GS
activity, S100B secretion, TNF-a, IL-1b and IL-6 levels in astroglial cells exposed to ammonia. Ammonia induced oxidative
stress, decreased GS activity and increased cytokines release, probably by a mechanism dependent on protein kinase A
(PKA) and extracellular signal-regulated kinase (ERK) pathways. Resveratrol prevented ammonia toxicity by modulating
oxidative stress, glial and inflammatory responses. The ERK and nuclear factor-kB (NF-kB) are involved in the protective
effect of resveratrol on cytokines proinflammatory release. In contrast, other antioxidants (e.g., ascorbic acid and trolox)
were not effective against hyperammonemia. Thus, resveratrol could be used to protect against ammonia-induced
neurotoxicity.
Citation: Bobermin LD, Quincozes-Santos A, Guerra MC, Leite MC, Souza DO, et al. (2012) Resveratrol Prevents Ammonia Toxicity in Astroglial Cells. PLoS
ONE 7(12): e52164. doi:10.1371/journal.pone.0052164
Editor: Ken Arai, Massachusetts General Hospital/Harvard Medical School, United States of America
Received May 10, 2012; Accepted November 15, 2012; Published December 21, 2012
Copyright:  2012 Bobermin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Conselho Nacional de Desenvolvimento Cientı́fico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal
de Nı́vel Superior (CAPES), FINEP/Rede IBN 01.06.0842-00 and INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: andrequincozes@yahoo.com.br
. These authors contributed equally to this work.
Introduction
Ammonia is implicated as a neurotoxin in brain metabolic
disorders associated with hyperammonemia, including hepatic
encephalopathy (HE), a neuropsychiatric syndrome, and deficien-
cies in enzymes of the urea cycle [1,2]. In these conditions,
ammonia concentrations in brain tissue can rise as high as 5 mM
[1]. Acute ammonia neurotoxicity can be mediated by an
excitotoxic mechanism involving the glutamatergic system, in-
cluding elevation of extracellular glutamate content, decreased
glutamate transporters, NMDA receptor activation and sub-
sequent increases in intracellular calcium concentration
[3,4,5,6,7]. Metabolic effects of ammonia neurotoxicity include
changes in reactive oxygen and nitrogen species (ROS/RNS)
levels [8], nitric oxide (NO) metabolism [2], cAMP levels [3,9],
mitogen-activated protein kinase (MAPK) pathway [10], cytoskel-
eton [11] and astrocyte swelling [12]. Moreover, ammonia toxicity
also induces increase in tumor necrosis factor a (TNF-a),
Interleukin 1b (IL-1b), which can be associated to ROS pro-
duction and involve protein kinase A (PKA), extracellular signal-
regulated kinase (ERK) and nuclear factor-kB (NF-kB) activation
[13]. Increased levels of S100B secretion, a protein often used as
an indicator of glial activation or death for several types of brain
injury [14,15], were also observed in astrocytes exposed to
ammonia [16].
Astrocytes serve a wide range of adaptive functions in the
mammalian central nervous system (CNS). These cells interact
with neurons, providing structural, metabolic and trophic support,
and they can also play a protective role by releasing neurotrophic
factors. In pathological circumstances, however, astrocytes have
the potential to induce neuronal dysfunction [17,18,19,20].
Astrocytes play an essential role in protecting neurons against
excitotoxicity by taking up excess ammonia and glutamate and
converting it into glutamine, using the enzyme glutamine
synthetase (GS) (EC 6.3.1.2) [21,22]. Under conditions of
ammonia toxicity, GS activity is decreased [3,16]. This enzyme
is very sensitive to oxidative stress, and it has been hypothesized to
play an important role in the pathogenesis of ammonia
neurotoxicity [23]. The C6 cell line are widely used to study
astrocytic functions such as glutamate metabolism (glutamate
uptake, GS activity and glutathione production), S100B secretion,
oxidative and inflammatory responses [24,25,26,27,28,29,30].
Antioxidants are substances that delay, prevent or reverse
oxidative damage to a target molecule [31]. Resveratrol, found in
grapes, berries and red wine, is an important antioxidant with
a wide range of biological effects. It inhibits carcinogenesis at
multiple stages and displays anti-inflammatory, cardioprotective,
neuroprotective and anti-aging activities [32,33,34]; however, the
mechanisms of these effects are not fully understood. Our group
has shown that resveratrol also modulates important glial functions
including glutamate uptake, GS activity, and glutathione content
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[27,35,36,37,38,39]. The recent literature show that resveratrol is
able to protect astrocytes and neurons against a variety of
oxidative insults [40,41,42,43].
We therefore investigated the effects of ammonia exposure on
ROS/RNS production, GS activity, S100B secretion, proinflam-
matory cytokines release and NF-kB levels in astroglial cells. We
evaluated the effect of resveratrol and other classical antioxidants
(ascorbic acid, Nv-nitro-L-arginine methyl ester (L-NAME) and
trolox) on ROS production and S100B secretion. The mechanism




Poly-L-lysine, resveratrol, ascorbic acid, trolox, L-NAME,
monoclonal anti-S100B (SH-B1), H-89, PD98059, sodium nitro-
prusside (SNP), propidium iodide (PI), methylthiazolyldiphenyl-
tetrazolium bromide (MTT) and 29-79-dichlorofluorescein diace-
tate (DCFH-DA) were purchased from Sigma (St. Louis, MO,
USA). Fetal bovine serum (FBS), Dulbecco’s modified Eagle
medium (DMEM) and other materials for cell culture were
purchased from Gibco BRL (Carlbad, CA, USA). Polyclonal anti-
S100B and anti-rabbit peroxidase were purchased from Dako
(Glostrup, Denmark) and Amersham (Buckinghamshire, UK),
respectively. All other chemicals were purchased from common
commercial suppliers.
C6 Astroglial Cell Culture
The C6 astroglial cell line was obtained from the American
Type Culture Collection (Rockville, MA, USA) and was cultured
according to a previously described procedure. The cells were
seeded in asks and cultured in DMEM (pH 7.4) containing 5%
FBS, 0.1% amphotericin B and 0.032% gentamicin. Cells were
maintained at a temperature of 37uC in an atmosphere of 5%
CO2/95% air. At log phase, cells were detached from the culture
asks using 0.05% trypsin/ethylenediaminetetracetic acid (EDTA)
and seeded (56103 cells/cm2) in 96-, 24- or 6-well plates.
Primary Astrocyte Cell Culture
Primary cortical astrocyte cultures from Wistar rats were
prepared as previously described [44]. All procedures were in
accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and were approved by the
Federal University of Rio Grande do Sul Animal Care and Use
Committee (process number 21215). Briefly, the cerebral cortex of
newborn Wistar rats (1–2 days old) was removed and mechanically
dissociated in Ca2+- and Mg2+- free Hanks’ balanced salt solution
(HBSS), pH 7.4, containing the following: 137 mM NaCl,
5.36 mM KCl, 0.27 mM Na2HPO4, 1.1 mM KH2PO4, and
6.1 mM glucose. The cortex was cleaned of the meninges and
mechanically dissociated by sequential passage through a Pasteur
pipette. After centrifugation at 1,000 rpm for 5 min, the pellet was
resuspended in DMEM (pH 7.6) supplemented with 8.39 mM
HEPES, 23.8 mM NaHCO3, 0.1% amphotericin B, 0.032%
gentamicin and 10% FBS. Approximately 300,000 cells were
seeded in each well of the 24-well plates and maintained in
DMEM containing 10% FBS in 5% CO2/95% air at 37uC. The
cells were allowed to grow to confluence and used after
approximately 15 days in vitro.
Treatments
At confluence, the culture medium was removed by suction, and
the cells were treated with ammonia and antioxidants (resveratrol,
L-NAME, ascorbic acid, trolox) at the indicated concentrations.
Cells were also pre-treated for 1 h with resveratrol (100 mM),
ascorbic acid (100 mM), trolox (50 mM) or L-NAME (500 mM) at
37uC in an atmosphere of 5% CO2/95% air in DMEM without
Figure 1. Effects of ammonia and antioxidants on DCFH
oxidation. Cells were incubated with ammonia (1, 5 and 10 mM) –
A, antioxidants (100 mM resveratrol (RSV), 500 mM L-NAME, 100 mM
ascorbic acid (AA) and 50 mM trolox (TRL)) – B, or antioxidants plus
ammonia (5 mM) – C, for 24 h. DCFH oxidation was measured as
described in the Materials and methods section. The line indicates the
control value. Data represent means 6 S.E.M of three experimental
determinations performed in triplicate, analyzed statistically by two-way
ANOVA followed by the Tukey’s test. (a) indicates significant differences
from the control (P,0.05). (b) indicates significant differences from
ammonia (P,0.05).
doi:10.1371/journal.pone.0052164.g001
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serum. Subsequently, 5 mM ammonia (NH4Cl) was added in the
presence or absence of resveratrol (100 mM), ascorbic acid
(100 mM), trolox (50 mM) or L-NAME (500 mM) for 24 h at
37uC in an atmosphere of 5% CO2/95% air in DMEM without
serum. For all parameters analyzed, the results obtained with
vehicle were not different from those obtained under basal
conditions.
To study the role of PKA and MEK/ERK pathways in the
response of resveratrol against ammonia toxicity, we pre-treated
the cells for 1 h with 10 mM H-89 and 5 mM PD98059, the
specific PKA and MEK inhibitors, respectively. The role of NO
metabolism was also evaluated using SNP, a NO donator (40 mM).
Membrane Integrity and Metabolic Activity Assays
Propidium iodide incorporation assay: Cells were treated
simultaneously with 7.5 mM PI and incubated for up to 24 h.
The optical density of uorescent nuclei (labeled with PI), indicative
of cell death, was determined with Optiquant software (Packard
Figure 2. Effects of ammonia and antioxidants on NO levels. The production of NO was indirectly measured by the formation of nitrite. Cells
were incubated for 24 h with 100 mM resveratrol (RSV) or 500 mM L-NAME in the presence or absence of 5 mM ammonia (A). Cells were treated with
40 mM SNP in the presence or absence of 100 mM resveratrol (RSV) or 500 mM L-NAME and 5 mM ammonia, for 24 h (B). Nitrite levels were measured
as described in the Materials and methods section. The line indicates the control value. Data represent means 6 S.E.M of three experimental
determinations performed in triplicate, analyzed statistically by two-way ANOVA followed by the Tukey’s test. (a) Indicates significant differences from
the control (P,0.05). (b) indicates significant differences from ammonia (P,0.05). (c) indicates significant differences from SNP (P,0.05).
doi:10.1371/journal.pone.0052164.g002
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Instrument Company). Density values obtained are expressed as
a percentage of the control values.
Lactate dehydrogenase assay: The lactate dehydrogenase (LDH)
assay was conducted in 50 mL of extracellular medium using
a commercial colorimetric assay from Doles (Brazil). Results are
expressed as percentages of the control value.
MTT reduction assay: Cells were treated with 50 mg/mL MTT
for 30 min in 5% CO2/95% air at 37uC. Subsequently, the
medium was removed, and the MTT crystals were dissolved in
DMSO. Absorbance values were measured at 560 and 650 nm.
Results are expressed as percentages of the control value.
DCFH Oxidation
Intracellular ROS production was detected using the non-
fluorescent cell-permeating compound, 29-79-dichlorofluorescein
diacetate (DCFH-DA). DCFH-DA is hydrolyzed by intracellular
esterases to dichlorofluorescin (DCFH), which is trapped within
the cell. This non-fluorescent molecule is then oxidized into
fluorescent dichlorofluorescin (DCF) by the action of cellular
Figure 3. Effects of ammonia and antioxidants on GS activity. Cells were incubated for 24 h with 100 mM resveratrol (RSV) or 500 mM L-NAME
in the presence or absence of ammonia (5 mM) – A. Cells were treated with 40 mM SNP in the presence or absence of 100 mM resveratrol (RSV) or
500 mM L-NAME and 5 mM ammonia, for 24 h – B. GS activity was measured as described in the Materials and methods section. The line indicates the
control value. Data represent means 6 S.E.M of three experimental determinations performed in triplicate, analyzed statistically by two-way ANOVA
followed by the Tukey’s test. (a) Indicates significant differences from the control (P,0.05). (b) indicates significant differences from ammonia
(P,0.05). (c) indicates significant differences from SNP (P,0.05).
doi:10.1371/journal.pone.0052164.g003
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oxidants. Cultured cells were treated as described above. Cells were
then incubated with DCFH-DA (10 mM) for 30 min at 37uC.
Following DCFH-DA exposure, the cells were scraped into PBS
with 0.2% Triton X-100. The fluorescence was measured in a plate
reader (Spectra Max GEMINI XPS, Molecular Devices, USA)
with excitation at 485 nm and emission at 520 nm [38]. Results
are expressed as percentages of the control value.
Nitric Oxide Production
Nitric oxide was determined by measurement of nitrite (a stable
oxidation product of NO), based on the Griess reaction. The
Griess reagent was prepared by mixing equal volumes of 1%
sulfanilamide in 0.5 N HCl and 0.1% N-(1-naphthyl) ethylene-
diamine in deionized water. The assay was performed as described
[45] with modifications. Briefly, cells were cultured on 96-well
plate and after treatment, the Griess reagent was added directly to
the cell culture and the incubation was maintained under reduced
light at room temperature during 15 min. Samples were analyzed
at 550 nm on a microplate spectrophotometer. Controls and
blanks were run simultaneously. Nitrite concentrations were
calculated using a standard curve prepared with sodium nitrite
(0–50 mM).
Glutamine Synthetase Activity
The enzymatic assay was performed as previously described
[27]. Briefly, homogenate was added to a reaction mixture
containing 10 mM MgCl2, 50 mM L-glutamate, 100 mM imid-
azole-HCl buffer (pH 7.4), 10 mM 2-mercaptoethanol, 50 mM
hydroxylamine–HCl and 10 mM ATP and incubated for 15 min
at 37uC. The reaction was stopped by adding a solution containing
370 mM ferric chloride, 670 mM HCl and 200 mM trichloroa-
Figure 4. Effect of ammonia on S100B secretion in C6 astroglial
cells. Cells were incubated for 1, 6 and 24 h with ammonia (1, 5 and
10 mM). S100B extracellular (A) and intracellular (B) content was
measured as described in the Materials and methods section. The basal
secretion level, assumed to be 100%, is indicated by the line. Data
represent means 6 S.E.M of three experimental determinations
performed in triplicate, analyzed statistically by one-way ANOVA
followed by the Tukey’s test. (a) indicates significant differences from
the control (P,0.05).
doi:10.1371/journal.pone.0052164.g004
Figure 5. Effect of antioxidants on ammonia-induced S100B
secretion in C6 astroglial cells and primary astrocyte cultures.
C6 astroglial cells (A) and primary astrocytes (B) were pre-treated for
1 h with 100 mM resveratrol (RSV), 500 mM L-NAME, 100 mM ascorbic
acid (AA) or 50 mM trolox (TRL). After pre-treatment, ammonia (5 mM)
was added in the presence or absence of these antioxidants. The basal
secretion level, assumed to be 100%, is indicated by the line. Data
represent means 6 S.E.M of three experimental determinations
performed in triplicate, analyzed statistically by two-way ANOVA
followed by the Tukey’s test. (a) indicates significant differences from
the control (P,0.05). (b) indicates significant differences from ammonia
(P,0.05).
doi:10.1371/journal.pone.0052164.g005
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cetic acid. After centrifugation, the absorbance of the supernatant
was measured at 530 nm and compared to a calibration curve of
c-glutamylhydroxamate treated with ferric chloride reagent.
Results are expressed as percentages of the control value.
S100B Secretion Assay
S100B secretion was measured by an enzyme-linked immuno-
sorbent assay, as previously described [46]. Briefly, 50 mL of
sample and 50 mL of Tris buffer were incubated for 2 h on
a microtiter plate previously coated with monoclonal anti-S100B
(SH-B1). Next, the samples were incubated with polyclonal anti-
S100B for 30 min, and then, peroxidase-conjugated anti-rabbit
antibody was added for a further 30 min incubation period. A
colorimetric reaction with o-phenylenediamine was observed at
492 nm. Results are expressed as percentages of the control value.
Figure 6. Effect of simultaneous resveratrol and L-NAME
treatment and SNP on ammonia-induced S100B secretion in
C6 astroglial cells. Cells were pre-treated with 100 mM resveratrol
(RSV) and 500 mM L-NAME simultaneously, in the presence of 5 mM
ammonia for 24 h (A). Cells were pre-treated for 1 h with 100 mM
resveratrol (RSV) or 500 mM L-NAME, followed by incubation with
40 mM SNP for 24 h (B). The basal secretion level, assumed to be 100%,
is indicated by the line. Data represent means 6 S.E.M of three
experimental determinations performed in triplicate, analyzed statisti-
cally by two-way ANOVA followed by the Tukey’s test. (a) indicates
significant differences from the control (P,0.05). (b) indicates
significant differences from ammonia (P,0.05). (c) indicates significant
differences from SNP (P,0.05).
doi:10.1371/journal.pone.0052164.g006
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Tumor Necrosis Factor a Measurement
TNF-a assay was carried out in extracellular medium, using
a rat TNF-a ELISA from PeproTech (USA).
Interleukins Measurement
IL-1b and IL-6 was carried out in cell culture supernatant, using
the rat ELISA for IL-1b and IL-6, respectively, from eBioscience
(USA).
Nuclear Factor-kB Measurement
The levels of NF-kB p65 were measured using an ELISA
commercial kit from Invitrogen (USA).
Protein Determination
Protein content was measured by Lowry’s method using bovine
serum albumin as the standard [47].
Statistical Analysis
Data are presented as mean 6 S.E.M. Each experiment was
performed in triplicate from at least three independent cultures.
The data were subjected to one/two-way analysis of variance
(ANOVA) followed by the Tukeys test. Values of P,0.05 were
considered significant. All analyses were performed using the
Statistical Package for the Social Sciences (SPSS) software.
Results
The integrity and metabolic activity of C6 astroglial cells
incubated with ammonia for 24 h, as evaluated by measuring PI
incorporation, extracellular LDH content and MTT reduction
(Table S1), did not significantly change relative to control
conditions. The antioxidants resveratrol, L-NAME, ascorbic acid
and trolox also did not produce significant changes in these cell
viability parameters (Table S2), with the exception of 100 mM
trolox. Morphological studies showed that ammonia exposure
induced astroglial swelling and cell body retraction and resveratrol
totally prevented this effect (Figure S1).
The production of ROS was monitored using DCFH oxidation.
The level of DCFH oxidation in C6 astroglial cells increased by
about 40% and 55% following treatment for 24 h with 5 and
10 mM ammonia, respectively, indicating an increase in ROS
production (Figure 1A). All of the antioxidants tested decreased the
basal level of DCFH oxidation (Figure 1B). Resveratrol was the
most active (35%), followed by L-NAME (25%), trolox (19%) and
ascorbic acid (15%). Next, we evaluated the effect of antioxidants
on ROS production in the presence of ammonia (Figure 1C).
Resveratrol and L-NAME successfully protected the cells; the
DCFH oxidation levels dropped from 14768.7% to 10367.6%
and 11469%, respectively. The production of NO was indirectly
measured by the formation of nitrite (Figure 2A). Both resveratrol
and L-NAME decreased nitrite production, 22% and 16%,
respectively, compared to the control conditions. Ammonia
increased nitrite formation up to 25%. This effect was completely
Figure 7. Effect of ammonia on cytokines release in C6
astroglial cells. Cells were incubated for 1, 6 and 24 h with ammonia
(1, 5 and 10 mM). TNF-a (A), IL-1b (B) and IL-6 (C) levels were measured
as described in the Materials and methods section. The basal cytokines
levels, assumed to be 100%, is indicated by the line. Data represent
means 6 S.E.M of three experimental determinations performed in
triplicate, analyzed statistically by one-way ANOVA followed by the
Tukey’s test. (a) indicates significant differences from the control
(P,0.05).
doi:10.1371/journal.pone.0052164.g007
Figure 8. Effect of resveratrol on ammonia-induced cytokines
in C6 astroglial cells. Cells were pre-treated for 1 h with 100 mM
resveratrol (RSV). After pre-treatment, ammonia (5 mM) was added in
the presence or absence of resveratrol. The basal cytokines levels,
assumed to be 100%, is indicated by the line. Data represent means 6
S.E.M of three experimental determinations performed in triplicate,
analyzed statistically by two-way ANOVA followed by the Tukey’s test.
(a) indicates significant differences from the control (P,0.05). (b)
indicates significant differences from ammonia (P,0.05).
doi:10.1371/journal.pone.0052164.g008
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prevented by resveratrol and L-NAME. SNP, a NO donator, was
used as a positive control for NO production (Figure 2B). SNP
(40 mM –24 h) increased by about 35% the nitrite levels compared
to basal cultures. Ammonia plus SNP also increased nitrite levels
(45%). Resveratrol and L-NAME totally prevent this effect,
restoring levels to control conditions.
Because GS is primarily responsible for clearing ammonia in the
CNS, we measured the GS activity of C6 astroglial cells following
exposure to ammonia (Figure 3A). GS activity decreased by about
19% compared to control conditions after exposure for 24 h to
5 mM ammonia. Because resveratrol and L-NAME effectively
prevented the induction of increased ROS production by
ammonia, we evaluated their effects on GS activity. Resveratrol
per se increased the activity of GS, by about 20% and completely
prevented the ammonia-induced decrease in GS activity
(8165.7% to 10267.9%), but L-NAME did not.
SNP was used indirectly to investigate whether the effect of
resveratrol on GS activity was mediated by NO (Figure 3B). SNP
decreased GS activity (16%) and also potentiated the decreased on
GS activity induced by ammonia (27%). Resveratrol co-incubated
with SNP and under ammonia exposure was able to prevent the
decrease. As expected, L-NAME blocked the effect of SNP on GS
activity. These data indicate that nitrosative stress and nitric oxide
synthase (NOS) activity can mediate the effect of resveratrol on GS
activity.
The secretion of S100B by C6 astroglial cells was not affected by
incubation with 1, 5 or 10 mM of ammonia for 1 h (Figure 4A).
After 6 h of treatment with 10 mM of ammonia, however, S100B
secretion increased by about 20%. Following 24 h of exposure to
ammonia, the level of extracellular S100B increased significantly,
by about 55% and 48% with 5 mM and 10 mM of ammonia,
respectively. Because changes in cell integrity were not observed,
the increased levels of extracellular S100B most likely resulted
from secretion. The intracellular S100B content, however, was not
affected by ammonia (Figure 4B). This result may indicate glial
activation because S100B was released without being over-
expressed.
Under ammonia-induced oxidative stress, resveratrol decreased
S100B secretion from 155614% to 10869%, relative to ammonia
per se (Figure 5A). L-NAME produced a similar effect. Ascorbic
acid and trolox maintained or did not significantly reduce the level
of ammonia-induced S100B secretion. As C6 cells and primary
astrocytes have shown contrasting profile of in vitro S100B
secretion [48], here we also examined the effect of ammonia
and antioxidants in primary astrocytes. Both stimuli produced
similar effects on S100B secretion by primary astrocytes
(Figure 5B), confirming in our study the similar responses between
these cells. It is important to mention that antioxidants per se did
not affect the levels of extracellular S100B in primary astrocytes
(data not shown).
Simultaneous addition of resveratrol and L-NAME reduced
S100B in C6 astroglial cells by about 55%, compared to ammonia
alone (Figure 6A). SNP was used to examine whether alterations
on S100B secretion was dependent of NO production (Figure 6B).
SNP increased 51% the S100B release. Resveratrol and L-NAME
restore the levels to near the basal values, indicating that the
increase in S100B is related to NO metabolism.
ROS play a critical role in inflammatory response. Moreover,
neuroinflammation has been described in a wide variety of
neurological disorders, including HE. In this sense, we evaluated
Figure 9. Effect of resveratrol on NF-kB levels in C6 astroglial
cells. Cells were pre-treated for 1 h with 100 mM resveratrol (RSV)
followed by incubation with 5 mM ammonia for 24 h. The basal NF-kB
level, assumed to be 100%, is indicated by the line. Data represent
means 6 S.E.M of three experimental determinations performed in
triplicate, analyzed statistically by two-way ANOVA followed by the
Tukey’s test. (a) indicates significant differences from the control
(P,0.05). (b) indicates significant differences from ammonia (P,0.05).
doi:10.1371/journal.pone.0052164.g009
Table 1. PKA pathway modulates ammonia-induced
cytokines release.
Treatments S100B TNF-a IL-1b IL-6
Ammonia 155614 (a) 148613 (a) 14069 (a) 135613 (a)
H-89 106610 10068 10168 93613
Ammonia+H-89 10869 (b) 109611 (b) 113615 (b) 120611 (b)
RSV+H-89 10569 (b) 10469 (b) 103611 (b) 109611 (b)
Ammonia+RSV+H89 9966 (b) 101610 (b) 10464 (b) 10568 (b)
C6 astroglial cells were pre-incubated with 10 mM PKA inhibitor (H-89), followed
by treatment with 100 mM resveratrol (RSV) and 5 mM ammonia for 24 h. Data
are expressed as percentage of control values and represent means 6 S.E.M of
three experimental determinations performed in triplicate, analyzed statistically
by two-way ANOVA followed by the Tukey’s test. (a) indicates significant
differences from the control (P,0.05). (b) indicates significant differences from
ammonia (P,0.05).
doi:10.1371/journal.pone.0052164.t001
Table 2. Resveratrol protects ammonia-induced cytokines
release through ERK signaling pathway.
Treatments S100B TNF-a IL-1b IL-6
Ammonia 153613 (a) 148613 (a) 14069 (a) 135613 (a)
PD 8969 (b) 103610 (b) 102611 (b) 93610 (b)
Ammonia+PD 11569 (a,b,c) 109610 (b) 108612 (b) 10969 (b)
RSV+PD 7265 (a,b,c) 88611 (b,c) 8769 (b,c) 8067 (a,b,c)
Ammonia+RSV+PD 8767 (a,b) 8569 (a,b,c) 81610 (a,b,c) 8369 (a,b,c)
C6 astroglial cells were incubated with 5 mM MEK/ERK inhibitor (PD98059–
referred in the table as PD), followed by treatment with 100 mM resveratrol
(RSV) and 5 mM ammonia for 24 h. Data are expressed as percentage of control
values and represent means 6 S.E.M of three experimental determinations
performed in triplicate, analyzed statistically by two-way ANOVA followed by
the Tukey’s test. (a) indicates significant differences from the control (P,0.05).
(b) indicates significant differences from ammonia (P,0.05). (c) indicates
significant differences from MEK/ERK inhibitor (P,0.05).
doi:10.1371/journal.pone.0052164.t002
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the classical proinflammatory cytokine, TNF-a (Figure 7A). After
1 h of exposure, ammonia 10 mM increased TNF-a release by
about 19%. At 6 h, 5 and 10 mM ammonia increased TNF-
a release by about 32% and 39%, compared to control conditions,
respectively. Following 24 h of exposure to ammonia, all
concentrations increased TNF-a levels. IL-1b, another proin-
flammatory cytokine, was also measured (Figure 7B) and
a significant increase was observed at 1 h of 10 mM ammonia
exposure. An increase of 25% and 31% in IL-1b levels was
observed with 5 and 10 mM of ammonia, respectively, after 6 h
exposure. IL-1b increased from 1 mM ammonia and higher
concentrations at 24 h of exposure. Ammonia also modulated
positively the release of IL-6 (Figure 7C). At 6h, 10 mM ammonia
increased 18% IL-6 levels, compared to control conditions. After
24 h, 5 and 10 mM of ammonia induced a significant increase (by
about 35% and 41%, respectively) in the cytokine IL-6.
To determine whether resveratrol could modulate the ammo-
nia-stimulated proinflammatory cytokines, we evaluated the levels
of TNF-a, IL-1b and IL-6 in C6 astroglial cells. Resveratrol per se
did not affect the levels of these cytokines, but is able to completely
prevent the augment induced by ammonia exposure, decreasing
TNF-a levels from 148613% to 109613% (Figure 8A); IL-1b
levels from 14069% to 110613% (Figure 8B) and IL-6 from
135613% to 115616% (Figure 8C), values expressed as
percentage of control.
NF-kB is a transcription factor that induces the expression of
genes involved in many biological responses including inflamma-
tion [49]. Ammonia increased the NF-kB levels by about 43%
(Figure 9). Resveratrol alone did not significantly change the levels,
but it was able to prevent the increase induced by ammonia
exposure from 143616% to 105612%. As expected, H-89 and
PD98059 inhibited the NF-kB translocation (data not shown).
The effect of ammonia on cytokines release can involve many
pathways, one them involves cAMP. In fact, cAMP mediate
ammonia toxicity [50,51] and we investigated whether PKA was
involved in the increase of S100B secretion and proinflammatory
cytokines provoked by ammonia in C6 astroglial cells (Table 1).
Cells were pre-treated with a specific PKA inhibitor, H-89
(10 mM), and then incubated with ammonia. The PKA inhibitor
prevented the increase in S100B release after 24 h of incubation
with ammonia. H-89 also prevented the increase in ammonia-
stimulated proinflammatory cytokines. The co-incubation with
resveratrol, ammonia and H-89 did not show results different from
ammonia and H-89, indicating that resveratrol probably does not
act directly by PKA.
ERK pathway has also been implicated in the regulation of glial
inflammatory responses following an insult [52]. In this sense, we
examined the S100B and proinflammatory cytokines release using
a MEK/ERK inhibitor, PD98059 (Table 2). Under ammonia
exposure, MEK/ERK inhibitor prevented the increase in all
cytokines. Moreover, resveratrol potentiated the effect of PD98059
Figure 10. Proposed schematics of ammonia-induced cytokines and resveratrol protection in astroglial cells. Ammonia induces
increase in intracellular ROS production and cytokines, probably through cAMP/PKA, ERK and NO. Resveratrol (RSV) decreases the levels of ROS and
cytokines. The protective mechanism by which resveratrol prevents cytokines production is through inhibition of ERK signaling pathway and NF-kB
and reduction of NO levels. Thus, RSV protects astroglial cells against ammonia-induced oxidative stress and/or cytokines release.
doi:10.1371/journal.pone.0052164.g010
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in astroglial cells, decreasing the release of S100B, TNF-a, IL-1b
and IL-6 lower that ammonia plus PD98059. These results
indicated the involvement of ERK signaling in the protective
mechanism of resveratrol against hyperammonemia.
Discussion
Oxidative stress has been implicated in ammonia neurotoxicity
[10]. In the brain in vivo and in cultured cells, this condition results
in diminished antioxidant defense activity [53,54]. In this study,
we observed that treatment of C6 astroglial cells with ammonia
increased the level of DCFH oxidation and nitrite production.
Previously, Haghighat et al. [55] showed that ammonia interfered
with ATP production, leading to reduced levels of NADH and
increased NO levels, with subsequent nitration/inactivation of
enzymes [56]. We found that resveratrol and L-NAME, two
important antioxidants with many biological effects, prevented the
ammonia-induced increase of ROS/RNS production. This effect
may arise from improved antioxidant defense and/or from
inhibition of NOS.
In the CNS, ammonia is primarily detoxified in astrocytes by
the enzyme GS, which catalyses the ATP-dependent amidation of
glutamate to form glutamine. Continuing the glutamate-glutamine
cycle, the glutamine thus formed is exported to neurons, allowing
the synthesis of glutamate [57,58]. GS is very sensitive to oxidative
and nitrosative stress. Consistent with the results of Leite et al. [16],
we have demonstrated that ammonia toxicity decreases GS
activity in astroglial cells. Moreover, the NO metabolism seems
to be related to GS activity failure (Figure 3). Resveratrol acted as
scavenger more efficiently than L-NAME. Previously, we have
demonstrated that resveratrol per se increases values of glial
function parameters such as glutamate uptake, GS activity and
glutathione content under oxidative stress [27,36,38,39]. Recent
reports showed that HO1 (heme oxygenase 1) and its transcription
factor regulator, nuclear factor erythroid-2 related factor-2 (Nrf2),
might control the neuroprotective effect of resveratrol [59,60].
Resveratrol may therefore be effective against ammonia toxicity
either by its ROS/RNS-scavenging effect directly and/or by
inhibiting iNOS, a protein downstream of HO1 (Quincozes-
Santos, manuscript in revision) [61]. Additionally, the increase in
the activity of GS could be related to increased production of
glutathione, the main antioxidant of the CNS [22,62,63,64]. It is
important to mention that Nrf2 also facilitates the GSH synthesis
[65].
During this study, we also investigated the effect of ammonia on
the release of S100B from astroglial cells. Elevated serum levels of
S100B were observed in HE [66], and increased levels of S100B
secretion were also observed in astrocytes exposed to ammonia
[16]. We verified that S100B secretion was stimulated by ammonia
in the C6 astrocyte cell line. This effect cannot be attributed to
astroglial cell death because cell viability was not altered by
ammonia. It is widely known that S100B secretion is affected by
redox conditions and metabolic stress [38,48,67,68,69]. Increases
in extracellular S100B concentrations may be related to brain
damage/glial reactivity, and persistent high levels could be
involved in neurodegenerative disorders [14]. We observed that
increased S100B release was accompanied by increased ROS
production and decreased GS activity, indicating a glial response.
These effects may be associated with the impairment of several
cellular functions.
Hyperammonemia in glial cells results in increased cellular
levels of calcium and cAMP [3,9,51,70]. Both calcium and cAMP
have been proposed to mediate S100B release [71,72]. Treatment
with the PKA inhibitor H-89 completely prevented the ammonia-
induced increase of extracellular S100B levels. Moreover, ammo-
nia induces ERK activation [13] and the effect of S100B release
was totally abolished by MEK/ERK inhibitor, indicating that
cAMP/PKA and ERK are involved in this effect.
When astroglial cells were incubated with antioxidants and
ammonia, only resveratrol and L-NAME (an NOS-inhibitor)
protected against ammonia toxicity. Data on resveratrol and L-
NAME indicate that NO and/or its toxic derivative peroxynitrite
are probably involved in these effects. Co-incubation with
resveratrol and L-NAME produced a reduction in S100B
secretion, probably indicating an interaction between the two
compounds. We observed that SNP, a NO donator, stimulated the
S100B secretion, and resveratrol and L-NAME were able to
prevent this effect, indicating that both could act in the NO
pathway. Then, the mechanism by which resveratrol modulates
S100B secretion may therefore involve NO. It is important to
point out that the mechanisms of S100B secretion and action of
resveratrol are not well defined.
Ammonia also increased the main proinflammatory cytokines:
TNF-a and IL-1b. These cytokines have a major role in initiating
a cascade of activation of other cytokines and growth factor in
inflammatory response [73]. TNF-a is synthesized mainly by
microglia and astrocytes, and has several important functions in
the CNS, including astrocytes activation and glutamatergic
gliotransmission [30,73,74]. Recent studies show that proinflam-
matory cytokines are increased in HE [75,76], may be used as
a marker for encephalopathy grade. TNF-a and IL-1b acts since
acute inflammatory responses and both induces IL-6 synthesis
[73]. IL-6 is also produced in microglia, astrocytes and neurons,
and it plays a pivotal role in a variety of CNS functions such as
induction and modulation of astrocytes reactivation, pathological
inflammatory and neuroprotection. Assuming S100B as a cytokine,
it present the same profile of augment IL-6 and different of other
cytokines their present a duality of actions: degenerative and
reparative and/or anti and proinflammatory [77,78,79]. More-
over, the negative effects of these cytokines may be mediated by
TNF-a and IL-1b. Interestingly, as well as the effect on S100B was
via PKA and ERK, the increases of other cytokines were also
cAMP/PKA/ERK-dependent pathways.
The mechanism of NF-kB activation and subsequent trans-
location into the nucleus involves a variety of signaling pathways
and modifications, which are not completely understood [80]. A
significant increase in NF-kB levels was observed after treatment
of C6 cells with ammonia. NF-kB is a transcription factor involved
in immune and inflammatory reactions [81], which was inhibited
by resveratrol. This regulation could explain the decrease in
cytokines release. Besides, PKA and ERK signaling pathway can
activate NF-kB [41,49]. Resveratrol potentiated the effect of
MEK/ERK inhibitor and this data may provide a mechanistic
explanation for the protective effect of resveratrol against in-
flammatory cytotoxicity induced by ammonia. NF-kB also induces
the expression of iNOS [82]. Thus, we demonstrated that
resveratrol decreased S100B-ammonia induced through ERK
signaling, inhibition of NF-kB and NO metabolism.
TNF-a plays important roles in ROS production [83] and it
also potentiates NO production in astrocytes [84]. Thus, an
extracellular stimulus such as ammonia induces an increase in
ROS/RNS production and in four cytokines, which are related to
redox environment; therefore, the augment may also be through
oxidative/nitrosative stress. In this sense, we observed that
resveratrol was able to prevent the cytokines increase induced by
ammonia exposure, probably through ERK signaling pathway, an
upstream signal transduction of NF-kB. Ammonia induces, in
addition to overproduction of ROS, the protein tyrosine nitration
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and oxidation of RNA [85,86]. Our group recently demonstrated
that resveratrol prevented astroglial cells against H2O2-induced
genotoxicity [26,28]. Even though its mechanism of action
remains a mystery, resveratrol may exert its effects by antiox-
idant/scavenger activity, by modulated NO metabolism or by
anti-inflammatory effect [32,34,87,88]. As well, clinical studies
showed that N-acetylcysteine (NAC), an antioxidant precursor of
glutathione, present protection averts neuroinflammation due to
HE [75].
Our results suggest, for the first time, that resveratrol prevents
ammonia toxicity in astroglial cells by attenuating oxidative and
nitrosative stress, GS activity and cytokines release. Treatment of
C6 astroglial cells with ammonia induced increases in S100B,
TNF-a, IL-1b and IL-6 after 24 h of exposure via a mechanism
dependent upon PKA, ERK and NO. Resveratrol prevented
ammonia-induced cytokines release through inhibition of ERK
signaling pathway and NF-kB and reduction of NO levels. The
main conclusions about cytokines in this study are depicted in
Figure 10. Overall, these observations suggest that resveratrol may
potentially be useful for protection against oxidative stress and
inflammatory response in ammonia-induced gliopathy. However,
further studies are necessary to investigate the neuroprotective
effects of resveratrol against in vivo hyperammonemia in both
animal models and clinical trials.
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Figure S1 C6 astroglial cells morphology. Cells were
incubated for 24 h with 5 mM ammonia in the presence or
absence of 100 mM resveratrol (RSV). Under normal conditions
(Basal), the cells present polygonal morphology as shown by phase
contrast microscopy. Ammonia induced astrocyte swelling and
body retraction and RSV prevents this effect. Representative
images of three experiments performed in triplicate.
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Table S1 Effect of ammonia on membrane integrity and
metabolic activity in C6 astroglial cells. C6 astroglial cells
were incubated with ammonia (1, 5 and 10 mM) for 24 h.
Membrane integrity and metabolic activity were measured as
described in the Materials and methods section. Data are
expressed as percentage of control values and represent means
6 S.E.M of three experimental determinations performed in
triplicate, analyzed statistically by one-way ANOVA followed by
the Tukey’s test.
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